Tikhonova E P, Levchenko T P, Alesina M Iu, Langovaia N A
Probl Endokrinol (Mosk). 1979 Mar-Apr;25(2):33-8.
Three beta-adrenoblockers (trasicor, alpheprol, isoptin) were used in 68 patients with thyrotoxicosis in the complex therapy of the disease. Their effect on hemodynamic indices, urinary catecholamine excretion were studied, and the results of investigation were compared with the data obtained earlier with the use of anaprylin. The action of the latter on the thyroid metabolism was ascertained. Anaprylin proved to be the most effective of the aforementioned preparations. Trasicor, which was somewhat less effective, could be used in patients with thyrotoxicosis complicated by cardiovascular insufficiency due to its less pronounced inotropic action. Isoptin may be recommended as an anti-arrhythmic agent in thyrotoxicosis. The action mechanism of beta-adrenoblockers in thyrotoxicosis is suggested.
在68例甲状腺毒症患者的疾病综合治疗中使用了三种β-肾上腺素能阻滞剂(心得宁、阿普洛尔、异搏定)。研究了它们对血流动力学指标、尿儿茶酚胺排泄的影响,并将研究结果与先前使用心得安获得的数据进行了比较。确定了后者对甲状腺代谢的作用。心得安被证明是上述制剂中最有效的。心得宁的效果稍差,因其变力作用不太明显,可用于并发心血管功能不全的甲状腺毒症患者。异搏定可作为甲状腺毒症的抗心律失常药物推荐使用。文中提出了β-肾上腺素能阻滞剂在甲状腺毒症中的作用机制。